Contact
searchSearch
HMP Global
Login

Opioid Use Disorder

Featured

ASAM
Conference Coverage
ASAM 2026 to Showcase Transformative Care Models for Addiction, Psychiatric Comorbidities
04/23/2026
Brionna Mendoza
At the American Society of Addiction Medicine (ASAM) 2026 Annual Conference, hosted in San Diego on April 23-26, 2026, clinicians will explore numerous emerging strategies addressing substance use disorders (SUDs)
At the American Society of Addiction Medicine (ASAM) 2026 Annual Conference, hosted in San Diego on April 23-26, 2026, clinicians will explore numerous emerging strategies addressing substance use disorders (SUDs)
At the American Society of...
04/23/2026
Psych Congress Network
NYSAM 2026 Meeting Logo
Conference Coverage
NYSAM 2026 Spotlights Harm Reduction, Psychiatric Care in SUD Treatment
03/17/2026
Brionna Mendoza
At the 2026 New York Society of Addiction Medicine (NYSAM) Annual Conference in New York, clinicians and policymakers focused on integrating evolving policy with patient-centered addiction care.
At the 2026 New York Society of Addiction Medicine (NYSAM) Annual Conference in New York, clinicians and policymakers focused on integrating evolving policy with patient-centered addiction care.
At the 2026 New York Society of...
03/17/2026
Psych Congress Network
Evguenia Makovkina, MD
Conference Coverage
Education Intervention Boosts Psychiatrists’ Knowledge and Attitudes on mOUD
03/07/2026
Evguenia Makovkina, MD
Evguenia Makovkina, MD, discusses key findings from her pilot study examining psychiatrists’ baseline knowledge, attitudes, and prescribing practices related to medications for opioid use disorder (mOUD).
Evguenia Makovkina, MD, discusses key findings from her pilot study examining psychiatrists’ baseline knowledge, attitudes, and prescribing practices related to medications for opioid use disorder (mOUD).
Evguenia Makovkina, MD,...
03/07/2026
Psych Congress Network
pills spilling out of a tipped over pill bottle
News
Health Plan Disenrollment After MOUD Initiation Tied to Higher Mortality in US Cohort
03/05/2026
Maria Mantas
Health plan disenrollment after initiation of medications for opioid use disorder (MOUD) was associated with significantly increased all-cause and overdose mortality in a recent cohort study.
Health plan disenrollment after initiation of medications for opioid use disorder (MOUD) was associated with significantly increased all-cause and overdose mortality in a recent cohort study.
Health plan disenrollment after...
03/05/2026
Psych Congress Network
a group of clinicians
News
Collaborative Care Shows No Added Benefit for OUD With Depression or PTSD
01/02/2026
Maria Mantas
A collaborative care model tailored for low-resource primary care settings did not improve outcomes beyond enhanced usual care for adults with OUD and co-occurring depression and/or PTSD.
A collaborative care model tailored for low-resource primary care settings did not improve outcomes beyond enhanced usual care for adults with OUD and co-occurring depression and/or PTSD.
A collaborative care model...
01/02/2026
Psych Congress Network
a pencil on a paper quiz
Quiz
Self-Reported Rates of Illicitly Manufactured Fentanyl Use
06/11/2025
Maria Mantas
According to survey data collected in June 2024, what percentage of participants reported using illicitly manufactured fentanyl (IMF) within the past 12 months?
According to survey data collected in June 2024, what percentage of participants reported using illicitly manufactured fentanyl (IMF) within the past 12 months?
According to survey data...
06/11/2025
Psych Congress Network
pills
News
Prevalence of Illicit Opioid Use Higher Than Previously Estimated
06/04/2025
Maria Mantas
The rate of illicit opioid use, including illicitly manufactured fentanyl (IMF) use, in adults aged 18 and older was higher than previously estimated, according to recent findings.
The rate of illicit opioid use, including illicitly manufactured fentanyl (IMF) use, in adults aged 18 and older was higher than previously estimated, according to recent findings.
The rate of illicit opioid use,...
06/04/2025
Psych Congress Network
woman practicing mindfulness
News
Mindfulness Training Restores Reward System Function, Reduces Cravings, in OUD
06/02/2025
Jolynn Tumolo
A mindfulness-based training intervention called Mindfulness-Oriented Recovery Enhancement (MORE) improved positive emotion regulation, and subsequently reduced opioid craving, in patients with opioid use disorder (OUD).
A mindfulness-based training intervention called Mindfulness-Oriented Recovery Enhancement (MORE) improved positive emotion regulation, and subsequently reduced opioid craving, in patients with opioid use disorder (OUD).
A mindfulness-based training...
06/02/2025
Psych Congress Network
illustration of a quiz on a clipboard
Quiz
Using Appropriate Terminology for Pharmacologic OUD Treatment
05/14/2025
Maria Mantas
According to the American Psychiatry Association (APA) clinical guideline, which of the following terms are appropriate to use when referring to pharmacologic interventions for opioid use disorder (OUD)?
According to the American Psychiatry Association (APA) clinical guideline, which of the following terms are appropriate to use when referring to pharmacologic interventions for opioid use disorder (OUD)?
According to the American...
05/14/2025
Psych Congress Network
doctor looks through medical records
News
Automated Technique Identifies Problematic Opioid Use From EHR Notes
05/05/2025
Jolynn Tumolo
A machine learning approach that automated the Addiction Behaviors Checklist identified problematic opioid use in patients with chronic pain by analyzing electronic health record (EHR) notes, according to a recent study.
A machine learning approach that automated the Addiction Behaviors Checklist identified problematic opioid use in patients with chronic pain by analyzing electronic health record (EHR) notes, according to a recent study.
A machine learning approach that...
05/05/2025
Psych Congress Network
patient taking pills
News
Low-Dose Buprenorphine Initiation May Prevent Opioid Withdrawal in Some Patients
04/28/2025
Jolynn Tumolo
Just 7% of patients who received low-dose buprenorphine initiation (LDBI) for opioid use disorder (OUD) experienced clinically significant opioid withdrawal, according to an updated systematic review.
Just 7% of patients who received low-dose buprenorphine initiation (LDBI) for opioid use disorder (OUD) experienced clinically significant opioid withdrawal, according to an updated systematic review.
Just 7% of patients who received...
04/28/2025
Psych Congress Network

News

a group of clinicians
News
Collaborative Care Shows No Added Benefit for OUD With Depression or PTSD
01/02/2026
Maria Mantas
A collaborative care model tailored for low-resource primary care settings did not improve outcomes beyond enhanced usual care for adults with OUD and co-occurring depression and/or PTSD.
A collaborative care model tailored for low-resource primary care settings did not improve outcomes beyond enhanced usual care for adults with OUD and co-occurring depression and/or PTSD.
A collaborative care model...
01/02/2026
Psych Congress Network
pills
News
Prevalence of Illicit Opioid Use Higher Than Previously Estimated
06/04/2025
Maria Mantas
The rate of illicit opioid use, including illicitly manufactured fentanyl (IMF) use, in adults aged 18 and older was higher than previously estimated, according to recent findings.
The rate of illicit opioid use, including illicitly manufactured fentanyl (IMF) use, in adults aged 18 and older was higher than previously estimated, according to recent findings.
The rate of illicit opioid use,...
06/04/2025
Psych Congress Network
woman practicing mindfulness
News
Mindfulness Training Restores Reward System Function, Reduces Cravings, in OUD
06/02/2025
Jolynn Tumolo
A mindfulness-based training intervention called Mindfulness-Oriented Recovery Enhancement (MORE) improved positive emotion regulation, and subsequently reduced opioid craving, in patients with opioid use disorder (OUD).
A mindfulness-based training intervention called Mindfulness-Oriented Recovery Enhancement (MORE) improved positive emotion regulation, and subsequently reduced opioid craving, in patients with opioid use disorder (OUD).
A mindfulness-based training...
06/02/2025
Psych Congress Network
doctor looks through medical records
News
Automated Technique Identifies Problematic Opioid Use From EHR Notes
05/05/2025
Jolynn Tumolo
A machine learning approach that automated the Addiction Behaviors Checklist identified problematic opioid use in patients with chronic pain by analyzing electronic health record (EHR) notes, according to a recent study.
A machine learning approach that automated the Addiction Behaviors Checklist identified problematic opioid use in patients with chronic pain by analyzing electronic health record (EHR) notes, according to a recent study.
A machine learning approach that...
05/05/2025
Psych Congress Network
patient taking pills
News
Low-Dose Buprenorphine Initiation May Prevent Opioid Withdrawal in Some Patients
04/28/2025
Jolynn Tumolo
Just 7% of patients who received low-dose buprenorphine initiation (LDBI) for opioid use disorder (OUD) experienced clinically significant opioid withdrawal, according to an updated systematic review.
Just 7% of patients who received low-dose buprenorphine initiation (LDBI) for opioid use disorder (OUD) experienced clinically significant opioid withdrawal, according to an updated systematic review.
Just 7% of patients who received...
04/28/2025
Psych Congress Network
an assortment of pills spilled out on a yellow table
News
Inpatient Addiction Consultation Service Promotes MOUD in Patients With OUD
04/14/2025
Jolynn Tumolo
According to randomized clinical trial findings, patients with opioid use disorder (OUD) who received inpatient addiction consultation service were more likely to initiate medication for OUD (MOUD) compared to those who received usual care.
According to randomized clinical trial findings, patients with opioid use disorder (OUD) who received inpatient addiction consultation service were more likely to initiate medication for OUD (MOUD) compared to those who received usual care.
According to randomized clinical...
04/14/2025
Psych Congress Network
open and spilled bottle of pills
News
US Drug Overdose Deaths Show Steep Decline in Most Recent Data
04/07/2025
Jolynn Tumolo
Drug overdose deaths dropped almost 24% in the US for the 12 months ending in September 2024 compared with the previous year, according to provisional data from the Centers for Disease Control and Prevention (CDC).
Drug overdose deaths dropped almost 24% in the US for the 12 months ending in September 2024 compared with the previous year, according to provisional data from the Centers for Disease Control and Prevention (CDC).
Drug overdose deaths dropped...
04/07/2025
Psych Congress Network
US FDA sign
News
FDA Seeks Clearer Labeling for Transmucosal Buprenorphine Product Dosing
03/24/2025
Jolynn Tumolo
To avoid misperceptions that current labeling for buprenorphine-containing transmucosal products includes a maximum daily dose, the US Food and Drug Administration (FDA) is encouraging the submission of supplemental new drug applications to...
To avoid misperceptions that current labeling for buprenorphine-containing transmucosal products includes a maximum daily dose, the US Food and Drug Administration (FDA) is encouraging the submission of supplemental new drug applications to...
To avoid misperceptions that...
03/24/2025
Psych Congress Network
emergency room hospital waiting room reception area
News
Why Aren’t More Emergency Departments Using Medications for OUD Treatment?
03/12/2025
Jolynn Tumolo
Barriers may be hampering the use of medications for opioid use disorder (MOUD) in US emergency departments (EDs), according to results from a systematic review published in the Journal of Substance Use & Addiction Treatment.
Barriers may be hampering the use of medications for opioid use disorder (MOUD) in US emergency departments (EDs), according to results from a systematic review published in the Journal of Substance Use & Addiction Treatment.
Barriers may be hampering the...
03/12/2025
Psych Congress Network
Opioid Use Disorder Incidence Declines After State Policy Limits Opioid Prescriptions
News
Opioid Use Disorder Incidence Declines After State Policy Limits Opioid Prescriptions
02/24/2025
Jolynn Tumolo
New diagnoses of opioid use disorder in Vermont steadily lessened, most noticeably in young adults, after the state limited opioid analgesic prescriptions for acute pain in 2017. Researchers reported their findings in the American Journal of...
New diagnoses of opioid use disorder in Vermont steadily lessened, most noticeably in young adults, after the state limited opioid analgesic prescriptions for acute pain in 2017. Researchers reported their findings in the American Journal of...
New diagnoses of opioid use...
02/24/2025
Psych Congress Network
a young woman lies awake in bed
News
Adolescent Insomnia and Daytime Sleepiness Linked to Depression Risk
06/25/2026
Maria Mantas
A 3-year longitudinal study found that insomnia, excessive daytime sleepiness (EDS), and their co-occurrence were associated with increased risk of depression. 
A 3-year longitudinal study found that insomnia, excessive daytime sleepiness (EDS), and their co-occurrence were associated with increased risk of depression. 
A 3-year longitudinal study...
06/25/2026
Psych Congress Network
A man with depression holds his head in his hands
Research Summary
Navacaprant Fails Late-Stage MDD Trials
06/22/2026
Brionna Mendoza
Navacaprant, a kappa opioid receptor antagonist for major depressive disorder treatment, failed to show statistically significant efficacy in two phase 3 trials.
Navacaprant, a kappa opioid receptor antagonist for major depressive disorder treatment, failed to show statistically significant efficacy in two phase 3 trials.
Navacaprant, a kappa opioid...
06/22/2026
Psych Congress Network
a man surrounded by alcohol and other substances on a table
News
Reduced Stimulant Use Outcomes May Reveal Treatment Effects Missed by Abstinence Measures
06/18/2026
Maria Mantas
Evaluating reduced stimulant use rather than complete abstinence outcomes in patients with stimulant use disorder could provide additional insight into treatment efficacy.
Evaluating reduced stimulant use rather than complete abstinence outcomes in patients with stimulant use disorder could provide additional insight into treatment efficacy.
Evaluating reduced stimulant use...
06/18/2026
Psych Congress Network
Viloxazine MOA Study image
News
New Study Clarifies Multimodal Mechanism of Viloxazine in ADHD
06/11/2026
New research further characterizes viloxazine’s pharmacologic profile, supporting a multimodal mechanism involving norepinephrine transporters and serotonin receptors.
New research further characterizes viloxazine’s pharmacologic profile, supporting a multimodal mechanism involving norepinephrine transporters and serotonin receptors.
New research further...
06/11/2026
Psych Congress Network
Weight scale and tape measure
News
Retrospective Cohort Study Explores Long-Term Growth Outcomes Following Pediatric Methylphenidate Use
06/11/2026
A retrospective cohort study examined the association between pediatric ADHD, methylphenidate exposure, and adult BMI and height outcomes. The findings suggest that ADHD—particularly when treated with methylphenidate—may be associated with...
A retrospective cohort study examined the association between pediatric ADHD, methylphenidate exposure, and adult BMI and height outcomes. The findings suggest that ADHD—particularly when treated with methylphenidate—may be associated with...
A retrospective cohort study...
06/11/2026
Psych Congress Network
a woman scrolls on her phone while laying in bed
News
US Study Finds No Link Between AI Use and Depression
05/28/2026
Maria Mantas
A recent target trial emulation found no evidence of a causal relationship between frequent AI use and increased depressive symptoms among adults.
A recent target trial emulation found no evidence of a causal relationship between frequent AI use and increased depressive symptoms among adults.
A recent target trial emulation...
05/28/2026
Psych Congress Network
A clinician in the lab pulls a psilocybin mushroom from a bag using tweezers major depressive disorder mdd treatment
News
Single-Dose Psilocybin Rapidly Improves MDD Symptoms, RCT Finds
05/19/2026
Brionna Mendoza
A single dose of psilocybin was associated with a significant reduction in depressive symptoms within 2 days of administration in patients with major depressive disorder (MDD), according to randomized control trial results.
A single dose of psilocybin was associated with a significant reduction in depressive symptoms within 2 days of administration in patients with major depressive disorder (MDD), according to randomized control trial results.
A single dose of psilocybin was...
05/19/2026
Psych Congress Network
injection for schizophrenia treatment
News
Once-Monthly Aripiprazole Demonstrates Favorable Benefit–Risk Profile in Schizophrenia Treatment
05/14/2026
Maria Mantas
Once-monthly aripiprazole 400 mg (AOM 400) demonstrated a favorable risk-benefit profile as an acute and long-term maintenance treatment in patients with schizophrenia.
Once-monthly aripiprazole 400 mg (AOM 400) demonstrated a favorable risk-benefit profile as an acute and long-term maintenance treatment in patients with schizophrenia.
Once-monthly aripiprazole 400 mg...
05/14/2026
Psych Congress Network
A man with depression holds his head in his hands
News
Lumateperone Tops Efficacy in Adjunctive Treatment for MDD, Review Finds
05/12/2026
Brionna Mendoza
A new systematic review and network meta-analysis published in JAMA Psychiatry evaluated the comparative efficacy and acceptability of the 5 FDA-approved atypical antipsychotics used as adjunctive therapy for major depressive disorder (MDD).
A new systematic review and network meta-analysis published in JAMA Psychiatry evaluated the comparative efficacy and acceptability of the 5 FDA-approved atypical antipsychotics used as adjunctive therapy for major depressive disorder (MDD).
A new systematic review and...
05/12/2026
Psych Congress Network
A boy eating junk food while using a laptop computer
News
The Link Between Ultra-Processed Foods and ADHD
05/12/2026
Recent findings point to a possible link between ADHD and higher intake of ultra-processed foods.
Recent findings point to a possible link between ADHD and higher intake of ultra-processed foods.
Recent findings point to a...
05/12/2026
Psych Congress Network

Quizzes

a pencil on a paper quiz
Quiz
Self-Reported Rates of Illicitly Manufactured Fentanyl Use
06/11/2025
Maria Mantas
According to survey data collected in June 2024, what percentage of participants reported using illicitly manufactured fentanyl (IMF) within the past 12 months?
According to survey data collected in June 2024, what percentage of participants reported using illicitly manufactured fentanyl (IMF) within the past 12 months?
According to survey data...
06/11/2025
Psych Congress Network
illustration of a quiz on a clipboard
Quiz
Using Appropriate Terminology for Pharmacologic OUD Treatment
05/14/2025
Maria Mantas
According to the American Psychiatry Association (APA) clinical guideline, which of the following terms are appropriate to use when referring to pharmacologic interventions for opioid use disorder (OUD)?
According to the American Psychiatry Association (APA) clinical guideline, which of the following terms are appropriate to use when referring to pharmacologic interventions for opioid use disorder (OUD)?
According to the American...
05/14/2025
Psych Congress Network
a dialogue bubble with the word "quiz"
Quiz
How do inpatient addiction consultation services impact MOUD initiation?
04/21/2025
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
04/21/2025
Psych Congress Network
an illustrated laptop screen displaying a quiz
Quiz
By What Percentage Did US Drug Overdose Deaths Decline in 2024?
04/10/2025
Maria Mantas
According to provisional data from the Center for Disease Control and Prevention (CDC), by what percentage did US drug overdose deaths decrease in the 12 months ending in September 2024 compared to the previous year?
According to provisional data from the Center for Disease Control and Prevention (CDC), by what percentage did US drug overdose deaths decrease in the 12 months ending in September 2024 compared to the previous year?
According to provisional data...
04/10/2025
Psych Congress Network
Did OUD diagnoses increase or decrease in VHA patients?
Quiz
Did OUD diagnoses increase or decrease in VHA patients?
02/25/2025
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
02/25/2025
Psych Congress Network
How many US Psychiatric Hospitals Provided Medications for OUD?
Quiz
How many US psychiatric hospitals provided medications for OUD?
02/06/2025
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
02/06/2025
Psych Congress Network
Which U.S. region saw the most fentanyl pill seizures in 2023?
Quiz
Which US region saw the most fentanyl pill seizures in 2023?
01/15/2025
Do you remember the details of this study?
Do you remember the details of this study?
Do you remember the details of...
01/15/2025
Psych Congress Network
After how many months is 'problematic' opioid use diagnosed as OUD?
Quiz
After how many months is 'problematic' opioid use diagnosed as OUD?
12/16/2024
Test your diagnostic knowledge!
Test your diagnostic knowledge!
Test your diagnostic knowledge!
12/16/2024
Psych Congress Network
Were OUD treatment discontinuation rates higher with methadone?
Quiz
Were OUD treatment discontinuation rates higher with methadone?
12/04/2024
Pop quiz!
Pop quiz!
Pop quiz!
12/04/2024
Psych Congress Network
Do adults who smoke use more opioids?
Quiz
Do adults who smoke cigarettes use more opioids?
11/22/2024
Do you remember this study?
Do you remember this study?
Do you remember this study?
11/22/2024
Psych Congress Network
Viloxazine MOA Study image
Quiz
Test Your Knowledge: New Study Clarifies Multimodal Mechanism of Viloxazine in ADHD
06/12/2026
New research suggests that viloxazine has a multimodal mechanism of action. Test your understanding with this short quiz.
New research suggests that viloxazine has a multimodal mechanism of action. Test your understanding with this short quiz.
New research suggests that...
06/12/2026
Psych Congress Network
Weight scale and tape measure
Quiz
Test Your Knowledge: Retrospective Cohort Study Explores Long-Term Growth Outcomes Following Pediatric Methylphenidate Use
06/12/2026
How well do you understand the relationship between pediatric attention-deficit/hyperactivity disorder, methylphenidate use in childhood, and growth outcomes in adulthood? Test your knowledge with this short, multiple-choice quiz.
How well do you understand the relationship between pediatric attention-deficit/hyperactivity disorder, methylphenidate use in childhood, and growth outcomes in adulthood? Test your knowledge with this short, multiple-choice quiz.
How well do you understand the...
06/12/2026
Psych Congress Network
Pop quiz written on a blackboard with white chalk
Quiz
Psilocybin Outcomes for MDD
06/11/2026
Brionna Mendoza
Test your knowledge of recent research with this quiz!
Test your knowledge of recent research with this quiz!
Test your knowledge of recent...
06/11/2026
Psych Congress Network
Desiree Matthews, PMHNP-BC
Quiz
Drug-Drug Considerations in TD Treatment
06/10/2026
Maria Mantas
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews,...
06/10/2026
Psych Congress Network
Desiree Matthews, PMHNP-BC
Quiz
Drug-Drug Considerations in TD Treatment
06/10/2026
Maria Mantas
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews, PMHNP-BC, recommend careful consideration of metabolic pathways when selecting a vesicular monoamine transporter 2 (VMAT2) inhibitor for tardive dyskinesia (TD) treatment?
Why does Desiree Matthews,...
06/10/2026
Psych Congress Network
Girl in a classroom staring off into the distance
Quiz
Test Your Knowledge – Beyond the Stereotype: Rethinking Sex Differences in ADHD Presentation
05/12/2026
Differences in ADHD presentation between males and females may affect diagnosis and outcomes. Evaluate your understanding of key clinical distinctions with this short quiz.
Differences in ADHD presentation between males and females may affect diagnosis and outcomes. Evaluate your understanding of key clinical distinctions with this short quiz.
Differences in ADHD presentation...
05/12/2026
Psych Congress Network
A boy eating junk food while using a laptop computer
Quiz
Test Your Knowledge: The Link Between Ultra-Processed Foods and ADHD
05/12/2026
How well do you understand the emerging evidence linking ultra-processed foods and ADHD? Assess your knowledge with this brief quiz.
How well do you understand the emerging evidence linking ultra-processed foods and ADHD? Assess your knowledge with this brief quiz.
How well do you understand the...
05/12/2026
Psych Congress Network
Nishi Bhopal, MD
Quiz
First Steps in Identifying Excessive Daytime Sleepiness
05/06/2026
Maria Mantas
What is the recommended first step to confirm whether a patient is experiencing excessive daytime sleepiness? Take this quick quiz to test your knowledge!
What is the recommended first step to confirm whether a patient is experiencing excessive daytime sleepiness? Take this quick quiz to test your knowledge!
What is the recommended first...
05/06/2026
Psych Congress Network
a printed test, pencil, and clock on a desk
Quiz
Mortality Risk in Bipolar II Disorder
04/30/2026
Maria Mantas
What was the association between all-cause mortality risk and bipolar II disorder? Test your knowledge with this quiz!
What was the association between all-cause mortality risk and bipolar II disorder? Test your knowledge with this quiz!
What was the association between...
04/30/2026
Psych Congress Network
an illustrated laptop screen displaying a quiz
Quiz
PGx Testing in MDD
04/27/2026
Maria Mantas
Can you recall how the use of pharmacogenomic testing impacted treatment outcomes in major depressive disorder (MDD)?
Can you recall how the use of pharmacogenomic testing impacted treatment outcomes in major depressive disorder (MDD)?
Can you recall how the use of...
04/27/2026
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Insights
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use